Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Ankrd44 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKRD44 mRNA | CTD | PMID:22079256 | Ankrd44 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of ANKRD44 mRNA | CTD | PMID:22206623 | Ankrd44 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ANKRD44 mRNA] | CTD | PMID:22206623 | Ankrd44 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ANKRD44 mRNA | CTD | PMID:32145629 | Ankrd44 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANKRD44 mRNA | CTD | PMID:19770486|PMID:19933214 | Ankrd44 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ANKRD44 mRNA | CTD | PMID:33387578 | Ankrd44 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ANKRD44 mRNA | CTD | PMID:32109520 | Ankrd44 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ANKRD44 mRNA | CTD | PMID:32109520 | Ankrd44 | Rat | 2-palmitoylglycerol | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ANKRD44 mRNA | CTD | PMID:37199045 | Ankrd44 | Rat | aflatoxin B1 | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ANKRD44 mRNA | CTD | PMID:19770486 | Ankrd44 | Rat | aflatoxin B1 | decreases methylation | ISO | ANKRD44 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ANKRD44 gene | CTD | PMID:27153756 | Ankrd44 | Rat | all-trans-retinoic acid | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ANKRD44 mRNA | CTD | PMID:21934132|PMID:33167477 | Ankrd44 | Rat | alpha-Zearalanol | increases expression | EXP | | 6480464 | Zeranol results in increased expression of ANKRD44 mRNA | CTD | PMID:35163327 | Ankrd44 | Rat | antirheumatic drug | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of ANKRD44 mRNA | CTD | PMID:24449571 | Ankrd44 | Rat | aristolochic acid A | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ANKRD44 mRNA | CTD | PMID:33212167 | Ankrd44 | Rat | arsenite(3-) | increases methylation | ISO | ANKRD44 (Homo sapiens) | 6480464 | arsenite results in increased methylation of ANKRD44 promoter | CTD | PMID:23974009 | Ankrd44 | Rat | benzo[a]pyrene | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ANKRD44 mRNA | CTD | PMID:20064835 | Ankrd44 | Rat | benzo[a]pyrene | affects methylation | ISO | ANKRD44 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ANKRD44 promoter | CTD | PMID:27901495 | Ankrd44 | Rat | benzo[a]pyrene | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of ANKRD44 mRNA | CTD | PMID:19770486|PMID:20713471|PMID:21715664 | Ankrd44 | Rat | benzo[b]fluoranthene | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of ANKRD44 mRNA | CTD | PMID:26377693 | Ankrd44 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ANKRD44 gene | CTD | PMID:28505145 | Ankrd44 | Rat | bisphenol A | affects methylation | ISO | ANKRD44 (Homo sapiens) | 6480464 | bisphenol A affects the methylation of ANKRD44 gene | CTD | PMID:31601247 | Ankrd44 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ANKRD44 mRNA | CTD | PMID:34947998 | Ankrd44 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ANKRD44 mRNA | CTD | PMID:32145629 | Ankrd44 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Ankrd44 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of ANKRD44 intron | CTD | PMID:28392331 | Ankrd44 | Rat | cadmium atom | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKRD44 more ... | CTD | PMID:35301059 | Ankrd44 | Rat | cadmium dichloride | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ANKRD44 more ... | CTD | PMID:35301059 | Ankrd44 | Rat | carbon nanotube | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of ANKRD44 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Ankrd44 | Rat | cisplatin | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of ANKRD44 mRNA | CTD | PMID:27392435 | Ankrd44 | Rat | cisplatin | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of ANKRD44 mRNA | CTD | PMID:27392435 | Ankrd44 | Rat | copper atom | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... | CTD | PMID:15467011 | Ankrd44 | Rat | copper(0) | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... | CTD | PMID:15467011 | Ankrd44 | Rat | Dibutyl phosphate | affects expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ANKRD44 mRNA | CTD | PMID:37042841 | Ankrd44 | Rat | dioxygen | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD44 mRNA | CTD | PMID:30529165 | Ankrd44 | Rat | dorsomorphin | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Ankrd44 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of ANKRD44 mRNA | CTD | PMID:29391264 | Ankrd44 | Rat | entinostat | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ANKRD44 mRNA | CTD | PMID:26272509 | Ankrd44 | Rat | entinostat | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Ankrd44 | Rat | epoxiconazole | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of ANKRD44 mRNA | CTD | PMID:35436446 | Ankrd44 | Rat | folic acid | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ANKRD44 mRNA] | CTD | PMID:22206623 | Ankrd44 | Rat | formaldehyde | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ANKRD44 mRNA | CTD | PMID:27905399 | Ankrd44 | Rat | Heptachlor epoxide | increases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Heptachlor Epoxide results in increased expression of ANKRD44 mRNA | CTD | PMID:25270620 | Ankrd44 | Rat | hydralazine | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKRD44 mRNA | CTD | PMID:17183730 | Ankrd44 | Rat | hydrogen peroxide | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of ANKRD44 mRNA | CTD | PMID:18951874 | Ankrd44 | Rat | lead diacetate | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | lead acetate results in increased expression of ANKRD44 mRNA | CTD | PMID:37939567 | Ankrd44 | Rat | lipopolysaccharide | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of ANKRD44 mRNA | CTD | PMID:35811015 | Ankrd44 | Rat | lipopolysaccharide | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANKRD44 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Ankrd44 | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of ANKRD44 mRNA | CTD | PMID:19564919 | Ankrd44 | Rat | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of ANKRD44 mRNA | CTD | PMID:19564919 | Ankrd44 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of ANKRD44 mRNA | CTD | PMID:30467583 | Ankrd44 | Rat | methotrexate | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of ANKRD44 mRNA | CTD | PMID:24449571 | Ankrd44 | Rat | methyl methanesulfonate | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ANKRD44 mRNA | CTD | PMID:23649840 | Ankrd44 | Rat | methylmercury chloride | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ANKRD44 mRNA | CTD | PMID:28001369 | Ankrd44 | Rat | nickel atom | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Nickel results in increased expression of ANKRD44 mRNA | CTD | PMID:24768652|PMID:25583101 | Ankrd44 | Rat | ozone | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased more ... | CTD | PMID:27106289|PMID:34911549 | Ankrd44 | Rat | paracetamol | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ANKRD44 mRNA | CTD | PMID:29067470 | Ankrd44 | Rat | phenobarbital | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ANKRD44 mRNA] | CTD | PMID:19482888 | Ankrd44 | Rat | phenobarbital | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of ANKRD44 mRNA | CTD | PMID:19482888 | Ankrd44 | Rat | pirinixic acid | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Ankrd44 | Rat | pirinixic acid | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ANKRD44 mRNA | CTD | PMID:17426115 | Ankrd44 | Rat | potassium chromate | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ANKRD44 mRNA | CTD | PMID:22079256 | Ankrd44 | Rat | potassium chromate | decreases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of ANKRD44 mRNA | CTD | PMID:22079256 | Ankrd44 | Rat | resveratrol | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of ANKRD44 mRNA | CTD | PMID:23557933 | Ankrd44 | Rat | rotenone | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Rotenone results in increased expression of ANKRD44 mRNA | CTD | PMID:29955902 | Ankrd44 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ANKRD44 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Ankrd44 | Rat | SB 431542 | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Ankrd44 | Rat | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of ANKRD44 mRNA | CTD | PMID:19564919 | Ankrd44 | Rat | SCH 23390 | decreases expression | EXP | | 6480464 | SCH 23390 results in decreased expression of ANKRD44 mRNA | CTD | PMID:19564919 | Ankrd44 | Rat | sodium arsenate | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | sodium arsenate results in decreased expression of ANKRD44 mRNA | CTD | PMID:21795629 | Ankrd44 | Rat | sodium arsenite | increases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of ANKRD44 protein | CTD | PMID:29044176 | Ankrd44 | Rat | sodium arsenite | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ANKRD44 mRNA | CTD | PMID:37682722 | Ankrd44 | Rat | sodium arsenite | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ANKRD44 mRNA | CTD | PMID:34032870|PMID:39719251 | Ankrd44 | Rat | succimer | multiple interactions | ISO | Ankrd44 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD44 mRNA | CTD | PMID:21641980 | Ankrd44 | Rat | sunitinib | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of ANKRD44 mRNA | CTD | PMID:31533062 | Ankrd44 | Rat | testosterone | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Testosterone results in increased expression of ANKRD44 mRNA | CTD | PMID:33359661 | Ankrd44 | Rat | theophylline | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Theophylline results in increased expression of ANKRD44 mRNA | CTD | PMID:18951874 | Ankrd44 | Rat | thimerosal | increases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Thimerosal results in increased expression of ANKRD44 mRNA | CTD | PMID:24675092 | Ankrd44 | Rat | thimerosal | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of ANKRD44 mRNA | CTD | PMID:27188386 | Ankrd44 | Rat | titanium dioxide | increases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ANKRD44 mRNA | CTD | PMID:23557971 | Ankrd44 | Rat | titanium dioxide | decreases methylation | ISO | Ankrd44 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of ANKRD44 gene | CTD | PMID:35295148 | Ankrd44 | Rat | titanium dioxide | increases methylation | ISO | Ankrd44 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of ANKRD44 promoter | CTD | PMID:35295148 | Ankrd44 | Rat | tungsten | decreases expression | ISO | Ankrd44 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ANKRD44 mRNA | CTD | PMID:30912803 | Ankrd44 | Rat | valproic acid | multiple interactions | ISO | ANKRD44 (Homo sapiens) | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of ANKRD44 mRNA; [NOG protein co-treated more ... | CTD | PMID:17183730|PMID:27188386 | Ankrd44 | Rat | valproic acid | increases expression | ISO | ANKRD44 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ANKRD44 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:29154799 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















